TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR Newswire•30/10/2026•16:05 ET
0
Key Highlights
- ➤TransMedics grants options for 71,815 shares and 47,924 RSUs to nine employees
- ➤CFO Fernando Araujo receives options for 34,419 shares and 22,969 RSUs
- ➤Option exercise price set at $66.90 per share
- ➤Awards granted as employment inducements under Nasdaq Rule 5635(c)(4)
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
ANDOVER, Mass., Oct. 30, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on October 28, 2026, the Company granted non-qualified stock options to purchase an aggregate of 71,815 shares of its common stock and an aggregate of 47,924 restricted stock units (RSUs) to nine employees. These awards were granted as a material inducement for each employee's entry into employment with TransMedics.
Get started
Create a free account to read the full story.